// App-Quantinova.ai

3297 : Altered mucus composition and bacterial dysbiosis promote development of colitis following chronic Notch inhibition

Researchers

Presenter

  • Ishfaq Ahmed

Principal Investigators

  • Badal Roy

  • Rita-marie McFadden

  • Shrikant Anant

  • Seth Septer

  • Shahid Umar

Medical Centers

  • Kansas University Medical Center, Kansas City, KS

  • University of Kansas, Kansas City, KS

  • Childrens Mercy Hospital, Kansas City, MO

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Colorectal Cancer

  • Dysbiosis

  • Ulcerative colitis

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final